Eli Lilly and Co (LLY)

LLY (NYSE:Drugs)
$71.23
neg -1.20
-1.60%
Today's Range: 70.25 - 71.36 | LLY Avg Daily Volume: 4,558,900
Last Update: 12/22/14 - 12:51 PM EST
Volume: 1,684,146
YTD Performance: 41.96%
Open: $71.32
Previous Close: $72.40
52 Week Range: $49.99 - $75.10
Oustanding Shares: 1,113,429,817
Market Cap: 80,667,990,242
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 1 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
Mean Rec. 2.10 2.29 2.29 2.29
Latest Dividend: 0.50
Latest Dividend Yield: 2.76%
Dividend Ex-Date: 02/11/15
Price Earnings Ratio: 28.98
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
28.98 29.00 25.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.82% 44.40% 77.71%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.30 0.00 0.00
Net Income 14.60 -0.08 -0.03
EPS 18.00 -0.05 -0.02
Earnings for LLY:
EBITDA 6.99B
Revenue 23.11B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.74 $0.73 $2.78 $3.13
Number of Analysts 8 2 12 11
High Estimate $0.80 $0.74 $2.83 $3.39
Low Estimate $0.70 $0.72 $2.71 $2.89
Prior Year $0.74 $0.70 $4.15 $2.78
Growth Rate (Year over Year) 0.00% 4.29% -33.11% 12.76%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishEli Lilly numbers boosted at Leerink

Dec 22, 2014 | 7:59 AM EST

Shares of LLY now seen reaching $76, according to Leerink Partners. Estimates also upped, given the company's solid clinical pipeline. Outperform rating. 

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

bullishEli Lilly upgraded at Morgan Stanley

Dec 11, 2014 | 7:24 AM EST

LLY was upgraded from Underweight to Overweight, Morgan Stanley said. $85 price target. Prospects of the company's pipeline are undervalued. 

By

Gary Dvorchak

 | Nov 6, 2014 | 10:30 AM EST

Get a head start on upcoming ex-dividend days.

By

Doug Kass

 | Oct 23, 2014 | 7:36 AM EDT
Where it began.
By

Jim Cramer

 | Oct 9, 2014 | 4:08 PM EDT

Stop picking on PepsiCo, Allergan and Apple.

bullishEli Lilly rated new Buy at Deutsche

Aug 27, 2014 | 7:17 AM EDT

Coverage of LLY was started with a Buy rating, Deutsche Bank said. $71 price target. Company is poised to return to growth in the coming years. 

bearishEli Lilly downgraded at Citi

Jul 31, 2014 | 8:08 AM EDT

LLY was downgraded to Neutral, Citigroup said. Alimta risks are under-appreciated in the market. 

By

Jim Cramer

 | Jul 28, 2014 | 6:45 AM EDT

If you insist on playing it, recognize the 50/50 nature of the scenario.

By

Scott Redler

 | Jul 23, 2014 | 7:12 PM EDT

Marathon Oil and Morgan Stanley have traded through our entry prices.

We are feeling the pain today with our long GILD calls, these things happen and is why we ...
Mostly good start to trading week unless you are in energy stocks, which is now being impa...
As of 9;38 AM Knowles Corp. (KN) was up $1.14 per share (+ 5.65%) on very high volume of m...
Markets look set to open this holiday shortened trading week slightly up based on current ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.